Abstract
TAFRO syndrome (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly) is an atypical manifestation of multicentric Castleman's disease. Although overproduction of interleukin-6, vascular endothelial growth factor, and other cytokines may partially explain the pathophysiology of this rare syndrome, the precise mechanisms underlying the renal dysfunction associated with the condition remain unclear. Here, we describe a case of a 69-year-old male with TAFRO syndrome. He was treated with immunosuppressive agents and his renal function improved. Tapering of immunosuppressive agents resulted in a deterioration of renal function and an elevation of C-reactive protein. After 20 months of treatment, the patient died from tuberculous peritonitis and gastrointestinal bleeding. An autopsy revealed miliary tuberculosis, mediastinal lymphadenopathy, and gastric ulcers. Renal histopathology showed a membranoproliferative glomerulonephritis-like appearance. Almost all glomeruli showed lobular formations with mesangial proliferation and duplication of glomerular capillary walls on light microscopy. Immunofluorescence showed deposition of C1q and IgM along the glomerular capillary walls. Electron microscopy showed mesan...Continue Reading
References
Jun 26, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·K FuruichiH Yokoyama
Oct 21, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Y NakamotoA B Miura
May 24, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Damin XuHong Zhang
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Hiroshi KawabataYasufumi Masaki
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Kazue TakaiTakako Saeki
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Hiroshi KawabataAkifumi Takaori-Kondo
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Yasufumi MasakiHisanori Umehara
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Noriko IwakiTadashi Yoshino
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Morihiro InoueYasunori Ota
Jul 3, 2013·Internal Medicine·Hiroshi KawabataAkifumi Takaori-Kondo
Aug 8, 2015·The Tohoku Journal of Experimental Medicine·Yoshinobu KonishiMitsuru Tsudo
Jan 20, 2016·Internal Medicine·Yusuke YamagaTakeshige Kunieda
Jan 26, 2016·American Journal of Hematology·Noriko IwakiYasuharu Sato
Mar 17, 2016·International Journal of Hematology·Shiho FujiwaraKisato Nosaka
Apr 17, 2016·International Journal of Hematology·Yasufumi MasakiSadao Aoki
Jun 9, 2016·The American Journal of Medicine·Akira TadokoroShuji Bandoh
Mar 30, 2017·Medicine·Fabio Freire JoséNelson Hamerschlak
Oct 7, 2017·Medicine·Mari TanakaHiroya Takeoka
Nov 22, 2017·Hematology/oncology Clinics of North America·Takuro Igawa, Yasuharu Sato
Nov 22, 2017·Hematology/oncology Clinics of North America·Angela DispenzieriFrancis Buadi
Nov 22, 2017·Hematology/oncology Clinics of North America·Raphaël Szalat, Nikhil C Munshi
Apr 8, 2018·Human Pathology·Hiroki MizunoYoshifumi Ubara
May 17, 2018·CEN Case Reports·Toshikazu OzekiShoichi Maruyama
Jun 15, 2018·Medicine·Yoshitaka FurutoYuko Shibuya
Citations
Jul 19, 2019·Frontiers in Immunology·Amélie LeursLouis Terriou
Jul 2, 2020·BMJ Case Reports·Sylvain Raoul Simeni NjonnouVirginie De Wilde
May 21, 2020·World Journal of Clinical Cases·Soya KobayashiTomoo Fujisawa
Apr 15, 2021·Kidney Medicine·Keiki ShimadaTakashi Yokoo